4.6 Article

D-Cycloserine: An Evolving Role in Learning and Neuroplasticity in Schizophrenia

期刊

SCHIZOPHRENIA BULLETIN
卷 38, 期 5, 页码 936-941

出版社

OXFORD UNIV PRESS
DOI: 10.1093/schbul/sbs012

关键词

NMDA; negative symptoms; memory consolidation; cognitive behavioral; therapy; D-cycloserine

资金

  1. National Institute of Mental Health (NIMH) [K24 MH002025]

向作者/读者索取更多资源

As a partial agonist at the glycine site of the NMDA receptor, D-cycloserine (DCS) has been viewed as lacking potency to fully test the NMDA receptor hypofunction theory of schizophrenia. However, findings of full agonist activity at a subset of NMDA receptors that may have particular relevance to schizophrenia, plus a growing body of evidence demonstrating enhancement of learning and neuroplasticity in animal models, suggest novel therapeutic strategies with DCS in schizophrenia. Preliminary studies with once-weekly administration have supported this potential new role for DCS in schizophrenia by demonstrating benefit for negative symptoms, memory consolidation, and facilitation of cognitive behavioral therapy for delusions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据